SCHEMBL23186753

SCHEMBL23186753

Nc1nc(-c2nn(Cc3ccccc3F)c3c(F)cccc23)ncc1C(=O)N1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BUB1 O43683 7/20 0.47
▸ ADORA3 P0DMS8 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ GUCY1A1 Q02108 9/20 0.42
▸ GUCY1B1 Q02153 9/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29381976 1.00 BUB1 (0.47) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL29382286 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL29381978 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL29381068 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL23186742 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL23186756 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL23186747 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL23186745 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL23186720 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1
SCHEMBL29379501 0.92 BUB1 (0.45) BUB1ADORA3KCNH2GUCY1A1GUCY1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609883-B1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2022-06-29 — — EP disclosed
US-11242335-B2 Fluorine-substituted indazole compounds and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-02-08 — — US disclosed
US-20210101882-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242335-B2 Fluorine-substituted indazole compounds and uses thereof GUCY1B2, GUCY1A2, PDE3A BUB1 4073/4885ADORA3 46/4885KCNH2 485/4885
US-20210101882-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF PDE3A, PDE3B, PDE5A BUB1 4579/4885ADORA3 43/4885KCNH2 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback